Haas Jason bought LGND
June 12, 2026 · Form 4 insider transaction
Haas Jason bought 3,000 shares of Ligand Pharmaceuticals Incorporated at $51.56 per share, a transaction worth $154.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,000
Price
$51.56
Total value
$154.7K
InsiderHaas Jason
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 12, 2026
Filing dateJune 15, 2026
Shares owned after10,442
OwnershipDirect
10b5-1 planNo
AmendedNo